Cargando…
Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries
Background: Ceftolozane/tazobactam (C/T) is a combination of an antipseudomonal oxyiminoaminothiazolyl cephalosporin with potent in vitro activity against Pseudomonas aeruginosa and tazobactam, a known β-lactamase inhibitor. The aim of this study was to evaluate the activity of C/T against clinical...
Autores principales: | García-Betancur, Juan Carlos, De La Cadena, Elsa, Mojica, María F., Hernández-Gómez, Cristhian, Correa, Adriana, Radice, Marcela A., Castañeda-Méndez, Paulo, Jaime-Villalon, Diego A., Gales, Ana C., Munita, José M., Villegas, María Virginia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405202/ https://www.ncbi.nlm.nih.gov/pubmed/36009970 http://dx.doi.org/10.3390/antibiotics11081101 |
Ejemplares similares
-
Molecular mechanisms leading to ceftolozane/tazobactam resistance in clinical isolates of Pseudomonas aeruginosa from five Latin American countries
por: Mojica, María F., et al.
Publicado: (2022) -
612. Molecular Mechanisms Leading to Ceftolozane–Tazobactam Resistance in Clinical Isolates of Pseudomonas aeruginosa from Five Latin American Countries
por: Mojica, Maria F, et al.
Publicado: (2019) -
Molecular Mechanisms of Resistance to Ceftazidime/Avibactam in Clinical Isolates of Enterobacterales and Pseudomonas aeruginosa in Latin American Hospitals
por: Mojica, María Fernanda, et al.
Publicado: (2023) -
In Vitro Susceptibility to Ceftazidime/Avibactam and Comparators in Clinical Isolates of Enterobacterales from Five Latin American Countries
por: Appel, Tobias Manuel, et al.
Publicado: (2020) -
1581. Comparative In Vitro Activity of Ceftolozane/tazobactam and Comparator Agents Against Enterobacteriaceae and Pseudomonas Aeruginosa Clinical Isolates in Colombia
por: Hernández-Gómez, Cristhian, et al.
Publicado: (2019)